Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024
AUTHORS
Moline
Heidi ,
Tannis
Ayzsa ,
Toepfer
Ariana ,
Halasa
Natasha ,
Dawood
Fatimah ,
. Morbidity and Mortality Weekly Report . 2024 3 7; ().
ABSTRACT
Tags: 2024 Alumni Publications